Rite Aid Nasal Spray Recalled for Manufacturing Quality Deviations
Product Quest Manufacturing LLC is recalling Rite Aid nasal spray due to manufacturing conditions that could impact product quality.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves CGMP deviations that could impact quality, but no specific injuries, illnesses, or high-risk pathogens are reported in the source text.
Plain-English summary
Product Quest Manufacturing LLC is recalling Rite Aid Pharmacy nasal relief NO DRIP PUMP SPRAY nasal spray (oxymetazoline hydrochloride 0.05%). The recall involves 114,336 bottles of the 1 FL OZ (30 mL) product, distributed nationwide in the USA. All lots remaining within expiry are affected.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. The source text states that the products were manufactured under conditions that could impact product quality.
Consumers should stop using the product and return it to the place of purchase for a refund or follow instructions from the recalling firm.
The recalled product
- Product
- Rite Aid Pharmacy, nasal relief NO DRIP PUMP SPRAY nasal spray, (oxymetazoline hydrochloride 0.05%), 12 Hour, 1 FL OZ (30 mL) bottle, Distributed By: Rite Aid, 30 Hunter Lane, Camp Hill, PA 17011, UPC 0 11822 31412 1.
- Manufacturer
- Product Quest Manufacturing LLC
- Category
- Drug — Nasal Spray
- Hazard
- Affected units
- 114,336
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots remaining within expiry.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 54 recalled by Product Quest Manufacturing LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 54 products in this recall →Related recalls
Same manufacturer · Product Quest Manufacturing LLC
See all →- ModeratePremier Value Sterile Saline Nasal Mist Recalled for Quality Concerns
FDA (Drugs) · 2018-10-24
- ModerateRhinall Nasal Decongestant Spray Recalled for Manufacturing Quality Deviations
FDA (Drugs) · 2018-10-24
- ModerateRhinall Nasal Decongestant Recalled for Manufacturing Quality Deviations
FDA (Drugs) · 2018-10-24
- ModerateCVS Health Saline Nasal Spray Recalled for Manufacturing Deviations
FDA (Drugs) · 2018-10-24
- ModerateQC Quality Choice Saline Nasal Gel Recalled for Quality Deviations
FDA (Drugs) · 2018-10-24
Same hazard · quality deviation
See all →- ModerateNarcan Nasal Spray Recalled for Temperature Excursions During Storage
FDA (Drugs) · 2021-06-02
- ModerateCardinal Health Recalls Meloxicam Tablets Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- ModerateCardinal Health Recalls LYRICA Capsules Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- ModerateCardinal Health Recalls Advair HFA Inhalers Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- ModerateCardinal Health Recalls Oseltamivir Phosphate Oral Suspension Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
Similar recalls
- ModerateOxymetazoline Nasal Spray Recalled Due to Manufacturing Process Deviation
FDA (Drugs) · 2024-01-10
- ModerateOTC Nasal Decongestant Recalled Due to Manufacturing Process Deviation
FDA (Drugs) · 2024-01-10
- ModerateOxymetazoline Nasal Spray Recalled Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- CriticalFDA Class I Drug Recall: Non-Sterile Multi-Action Relief Drops
FDA (Drugs) · 2024-02-14
- ModeratePerrigo Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- SevereFDA Recalls Lubricant Eye Drops Due to Non-Sterility
FDA (Drugs) · 2024-02-14